Patient-Specific iPSC-derived Cardiomyocytes for Drug Development and Toxicity Testing
Ulrich Broeckel,
Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics,
Medical College of Wisconsin
Using iPSC-derived cell types holds the promise to revolutionize drug development and toxicity testing. In particular, these cells provide a platform to incorporate both phenotypic variability and genetic diversity. In the presentation, we will discuss the impact of phenotypic and genetic diversity on drug screening and toxicity testing.
|
|
